Summary of Study ST001788

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001029. The data can be accessed directly via it's Project DOI: 10.21228/M8PM56 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST001788
Study Titleβ-Adrenergic regulation of metabolism in macrophages (part-IV)
Study SummaryMacrophages have important roles in the immune system including clearing pathogens and wound healing. Metabolic phenotypes have been associated with functional phenotypes, where pro-inflammatory macrophages have an increased rate of glycolysis and anti-inflammatory macrophages primarily use oxidative phosphorylation. β-adrenoceptor (βAR) signalling in macrophages has been implicated in disease states such as cancer, atherosclerosis and rheumatoid arthritis. The impact of β-adrenoceptor signalling on macrophage metabolism has not been defined. Here we expand on defining the phenotype of macrophages treated with isoprenaline and describe the impact that βAR signalling has on the metabolome and proteome. We found that βAR signalling alters proteins involved in cytoskeletal rearrangement and redox control of the cell. We showed that βAR signalling in macrophages shifts glucose metabolism from glycolysis towards the tricarboxylic acid cycle and pentose phosphate pathways. We also show that βAR signalling perturbs purine metabolism by accumulating adenylate pools. Taken together these results indicate that βAR signalling shifts metabolism to support redox perturbations and upregulate proteins involved in cytoskeletal changes that may impact migration and phagocytosis processes.
Institute
Monash University
Last NamePeterson
First NameAmanda
AddressDrug delivery, disposition and dynamics, Pharmacy and Pharmaceutical Sciences, 381 Royal Parade, Parkville, Victoria, 3052, Australia
Emailamanda.peterson@monash.edu
Phone99039282
Submit Date2021-05-13
Raw Data AvailableYes
Raw Data File Type(s)raw(Thermo)
Analysis Type DetailLC-MS
Release Date2021-05-28
Release Version1
Amanda Peterson Amanda Peterson
https://dx.doi.org/10.21228/M8PM56
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:

Factors:

Subject type: Cultured cells; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id treatment
SA166492M_labcontrol_2Control_13C-Glucose_4hr
SA166493M_labcontrol_3Control_13C-Glucose_4hr
SA166494M_labcontrol_4Control_13C-Glucose_4hr
SA166495CP_labcontrol_1Control_13C-Glucose_4hr
SA166496M_labcontrol_1Control_13C-Glucose_4hr
SA166497CP_labcontrol_2Control_13C-Glucose_4hr
SA166498CP_labcontrol_4Control_13C-Glucose_4hr
SA166499CP_labcontrol_3Control_13C-Glucose_4hr
SA166500M_labisoprenaline_3Isoprenaline_13C-Glucose_4hr
SA166501M_labisoprenaline_4Isoprenaline_13C-Glucose_4hr
SA166502CP_labisoprenaline_4Isoprenaline_13C-Glucose_4hr
SA166503M_labisoprenaline_2Isoprenaline_13C-Glucose_4hr
SA166504M_labisoprenaline_1Isoprenaline_13C-Glucose_4hr
SA166505CP_labisoprenaline_2Isoprenaline_13C-Glucose_4hr
SA166506CP_labisoprenaline_3Isoprenaline_13C-Glucose_4hr
SA166507CP_labisoprenaline_1Isoprenaline_13C-Glucose_4hr
Showing results 1 to 16 of 16
  logo